October 1, 2020 — VLP Therapeutics Japan, LLC (VLPTJ) announced on today that VLPTJ signed a contract manufacturing agreement with FUJIFILM Corporation (FUJIFILM) for a novel coronavirus (COVID-19) vaccine formulation developed by VLPTJ. This self-amplifying (replicon) RNA vaccine employs a platform technology proprietary to VLP Therapeutics, LLC, the US-based wholly owning parent company of VLPTJ.
“Structural studies of Chikungunya virus maturation” Moh Lan Yap, Thomas Klose, Akane Urakami, S. Saif Hasan, Wataru Akahata, and Michael G. Rossmann http://www.pnas.org/content/early/2017/11/29/1713166114.abstract?sid=89ef6c8b-994e-400d-af12-3726d0d40bbc
VLP Therapeutics Announces Phase 1 SBIR Grant Award From National Cancer Institute Grant will support development of novel Virus-Like Particle vaccine-based cancer immunotherapy October 6, 2017 Gaithersburg, MD – VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines announced today the receipt of a Phase I
“Envelope-modified tetravalent dengue virus-like particle vaccine: implication for flavivirus vaccine design” Akane Urakamia, Mya Myat Ngwe Tunb, Meng Ling Moib, Atsuko Sakuraia, Momoko Ishikawaa, Sachiko Kunoa, Ryuji Uenoa, Kouichi Moritab and Wataru Akahata http://jvi.asm.org/content/early/2017/09/21/JVI.01181-17.abstract
Gaithersburg, Md. — July 21, 2017 — VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the appointment of Jacob Licht as Chief Operating Officer. Mr. Licht comes to VLP Therapeutics with nearly 20 years of business development and strategy experience
“Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus” Akane Urakami, Atsuko Sakurai, Momoko Ishikawa, Moh Lan Yap, Yevel Flores-Garcia, Yasunari Haseda, Taiki Aoshi, Fidel P. Zavala, Michael G. Rossmann, Sachiko Kuno,a Ryuji Ueno, Wataru Akahata http://cvi.asm.org/content/24/7/e00090-17.full.pdf+html